Principal Financial Group
AVXL icon

Principal Financial Group’s Anavex Life Sciences AVXL Stock Holding History

Principal Financial Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,408
Closed -$48.1K – 2244
2024
Q2 		$48.1K Sell
11,408
-9,884
-46% -$40K ﹤0.01% 2288
2024
Q1 		$108K Buy
21,292
+428
+2% +$2.41K ﹤0.01% 2262
2023
Q4 		$194K Buy
20,864
+204
+1% +$1.4K ﹤0.01% 2175
2023
Q3 		$135K Sell
20,660
-295
-1% -$2.35K ﹤0.01% 2226
2023
Q2 		$170K Buy
20,955
+1,690
+9% +$14.5K ﹤0.01% 2206
2023
Q1 		$165K Sell
19,265
-1,439
-7% -$14.4K ﹤0.01% 2218
2022
Q4 		$192K Buy
20,704
+1,962
+10% +$21K ﹤0.01% 2206
2022
Q3 		$194K Sell
18,742
-393
-2% -$4.15K ﹤0.01% 2213
2022
Q2 		$192K Buy
19,135
+6,853
+56% +$64.9K ﹤0.01% 2305
2022
Q1 		$151K Buy
12,282
+874
+8% +$10.7K ﹤0.01% 2384
2021
Q4 		$198K Sell
11,408
-15,790
-58% -$300K ﹤0.01% 2369
2021
Q3 		$488K Buy
27,198
+1,234
+5% +$24.6K ﹤0.01% 2178
2021
Q2 		$594K Buy
25,964
+13,509
+108% +$200K ﹤0.01% 2167
2021
Q1 		$186K Sell
12,455
-1,240
-9% -$13.5K ﹤0.01% 2388
2020
Q4 		$74K Buy
+13,695
New +$72.2K ﹤0.01% 2377

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Principal Financial Group's AVXL Position: Q3 2024 in Review

Principal Financial Group sold out of Anavex Life Sciences (AVXL) in Q3 2024, closing a stake of 11,408 shares — an estimated $48.1K sold.

Principal Financial Group first reported a position in AVXL in Q4 2020 and held it in 15 quarters. The position peaked at $594K in Q2 2021. 145 funds tracked by Wall St. Rank hold AVXL as of Q3 2024.

  • Principal Financial Group reported no remaining Anavex Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Principal Financial Group sold 11,408 Anavex Life Sciences shares in Q3 2024, an estimated $48.1K.
  • Principal Financial Group first reported a position in Anavex Life Sciences in Q4 2020 and held it in 15 quarters.
  • Principal Financial Group's Anavex Life Sciences position peaked at $594K in Q2 2021.
  • 145 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2024.

Based on Principal Financial Group's 13F filing for Q3 2024, filed 31 Oct 2024.